[CAS NO. 1417329-24-8]  MM-102

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [1417329-24-8]

Catalog
SLK-S7265
Brand
Selleck
CAS
1417329-24-8

DESCRIPTION [1417329-24-8]

Overview

MDLMFCD28015099
Molecular Weight669.8
Molecular FormulaC35H49F2N7O4
SMILESO=C(C1(NC([C@@H](NC(C(NC(C(C)C)=O)(CC)CC)=O)CCCNC(N)=N)=O)CCCC1)NC(C2=CC=C(F)C=C2)C3=CC=C(F)C=C3

For research use only.

Storage

3 years,-20°C,powder
1 years,-80°C,in solvent

Shipping

Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

1 mg5 mg10 mg
1 mM1.4930 mL7.4649 mL14.9298 mL
5 mM0.2986 mL1.4930 mL2.9860 mL
10 mM0.1493 mL0.7465 mL1.4930 mL
50 mM0.0299 mL0.1493 mL0.2986 mL

Description

MM-102 (HMTase Inhibitor IX) is a high-affinity peptidomimetic inhibitor of the protein-protein interaction, which bind to WDR5 with Ki < 1 nM and =2.4nM.

Targets

MLL1 [1]
(Cell-free assay)
0.4 μM

In vitro

MM-102, as a MLL1 mimetic, shows high binding affinities to WDR5 with IC50 of 2.9 nM and K of < 1 nM. In the MLL1-AF9 transduced murine cells, MM-102 specifically reduces expression of two critical MLL1 target genes (HoxA9 and Meis-1), which are required for MLL1 mediated leukemogenesis. In addition, MM-102 effectively and selectively inhibits cell growth and induces apoptosis in leukemia cells harboring MLL1 fusion proteins.